HOOKIPA Pharma Inc. (HOOK)

Business: HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform.

IPO Date: 18-Apr-2019

CEO & Director: Mr. Joern Aldag

CFO & Director: Dr. Reinhard Kandera Ph.D.

Listing: NASDAQ: HOOK

Country: United States

Headquarters: New York, NY

Website: https://www.hookipapharma.com

Market cap: $94.62 Mln

Revenue (TTM): $5.34 Mln

Earnings (TTM): $-76.40 Mln

Cash: $140.83 Mln

Total Debt: $10.47 Mln

Insider's Holding: 8.39%

Liquidity: Low

52 Week range: $1.25 - 9.45

Shares outstanding: 50,872,700

5 Years Aggregate:

• CFO: $-174.00 Mln
• EBITDA: $-182.94 Mln
• Net Profit: $-191.74 Mln